Reduced Leaflet Motion in Bioprosthetic Aortic Valves--The FDA Perspective

N Engl J Med. 2015 Nov 19;373(21):1996-8. doi: 10.1056/NEJMp1512264. Epub 2015 Oct 5.
No abstract available

Publication types

  • Comment

MeSH terms

  • Anticoagulants / therapeutic use*
  • Aortic Valve / physiopathology*
  • Bioprosthesis / adverse effects*
  • Female
  • Heart Valve Diseases / etiology*
  • Heart Valve Prosthesis / adverse effects*
  • Humans
  • Male
  • Thrombosis / etiology*

Substances

  • Anticoagulants